Amgen and Allergan’s biosimilar of Roche’s cancer blockbuster Avastin has been approved in the EU, but there could be a four-year wait before the drug makes it to the market. The patent protecting ...
* U.S. FDA says Mvasi is approved for the treatment of adult patients with certain colorectal, lung, brain, kidney and cervical cancers Further company coverage: ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback